Tamoxifen-RAD001 Versus Tamoxifen Alone in Patients With Anti-aromatase Resistant Breast Metastatic Cancer

Clinical trial NCT01298713 · COMPLETED

Trial details

NCT number: NCT01298713
Sponsor: ARCAGY/ GINECO GROUP
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Breast Neoplasms mTor Protein

Start date: 2008-03-01
Primary completion: 2011-06-01
Enrollment: 111

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.